1. Substantiation and the Burden of Proof
Substantiation is the cornerstone of any marketing defense. When a corporation makes an affirmative claim about a product or service, regulators and plaintiffs typically require the company to possess competent and reliable evidence supporting that claim before the statement is made. This standard varies depending on the type of claim: health-related claims often require clinical studies or expert testimony, while performance claims may rely on internal testing or industry benchmarks.
Courts and regulatory agencies examine whether a company's substantiation was reasonable under the circumstances. A corporation cannot simply assert that a product is the best or most effective without documentary support. From a practitioner's perspective, the difference between a defensible claim and an indefensible one often turns on whether the company maintained contemporaneous records of testing, consumer surveys, or expert evaluations. The burden typically rests on the corporation to produce this evidence, particularly in regulatory enforcement actions or class action litigation.
Timing and Documentation Requirements
Documentation must be created or obtained before marketing materials are disseminated. Courts and the Federal Trade Commission scrutinize whether substantiation existed at the time the claim was made, not whether it can be retrofitted afterward. A company that conducts testing only after receiving consumer complaints or regulatory inquiries faces significant credibility challenges. New York state courts, when reviewing consumer protection claims under General Business Law Section 349, often examine whether the company maintained written records of substantiation contemporaneous with the advertisement's publication date.
2. Deception and Consumer Interpretation
Marketing defense also requires demonstrating that the challenged statements are not deceptive under applicable law. Deception is typically measured from the perspective of the reasonable consumer or the ordinary consumer, not the most sophisticated reader. A corporation must show that its language, visual elements, and overall presentation would not mislead a typical member of the target audience.
Ambiguity in marketing language creates risk. If a claim can be reasonably interpreted in two ways, and one interpretation is false or unsupported, the corporation may face liability even if it intended the other interpretation. Disclaimers and qualifying language matter significantly, but they must be clear, conspicuous, and actually communicated to consumers. Courts often hold that fine-print disclaimers cannot cure a false headline claim.
Omissions and Half-Truths
Marketing defense extends to what a company does not say. Under consumer protection statutes, an omission of material information can constitute deceptive conduct if the omitted fact would likely affect consumer choice. For example, if a product carries significant limitations, health risks, or performance boundaries, failure to disclose these facts may render marketing claims deceptive even if each stated fact is technically true. A corporation must evaluate whether the overall net impression of its marketing is misleading because of what is withheld.
3. Regulatory Compliance and Comparative Claims
Corporations often make comparative or superiority claims in advertising. These claims trigger heightened scrutiny under both federal and state law. When a company asserts that its product is better, safer, or more effective than competitors, it must possess reliable evidence comparing its product directly to competitors' products under substantially equivalent conditions. Vague comparisons or claims not grounded in documented testing face challenge.
Compliance with advertising and marketing law requires ongoing monitoring of regulatory guidance and case law developments. The FTC and state attorneys general regularly issue guidance on substantiation standards for specific product categories, and corporations that fail to track these updates risk enforcement action. In our experience, companies that maintain compliance programs, including regular audits of marketing materials and substantiation files, significantly reduce exposure to regulatory and private litigation.
Substantiation for Health and Environmental Claims
Health claims and environmental claims face the most rigorous substantiation requirements. A company claiming that a product reduces cholesterol, prevents disease, or is eco-friendly must possess clinical evidence, expert opinion, or validated testing protocols. The FTC has issued detailed guidance on substantiation for these categories, and failure to meet the specified standard can result in enforcement action and corrective advertising orders. Courts recognize that consumers place particular trust in health and environmental claims, and therefore require correspondingly strong substantiation.
4. Practical Considerations for Corporate Compliance
Building a marketing defense begins well before any regulatory inquiry or lawsuit. Corporations should implement policies requiring that all material claims be substantiated before publication. This includes creating a centralized substantiation file for each product line or service offering, documenting the basis for comparative claims, and ensuring that disclaimers are appropriately placed and legible.
Training marketing and sales personnel on substantiation requirements and compliance standards reduces the risk that unauthorized or unsubstantiated claims will be made. When a corporation receives a cease-and-desist letter or regulatory inquiry, it must be prepared to produce substantiation files quickly and completely. Delays or gaps in documentation often trigger additional scrutiny and may suggest that the company lacked reasonable confidence in its claims when they were made.
Record Retention and Litigation Readiness
Corporations should retain substantiation records, internal communications about claim development, and testing data for a period extending well beyond the typical statute of limitations for consumer protection claims. In New York, claims under General Business Law Section 349 may be brought within three years of the alleged deceptive practice, but class action litigation can extend this timeline significantly. Courts have found that a company's failure to maintain adequate records or its destruction of records after a lawsuit is threatened can support adverse inferences about the company's knowledge or intent. Documentation systems that clearly show when substantiation was obtained and how it was used to inform marketing decisions provide the strongest defense.
| Claim Category | Substantiation Standard | Key Risk Areas |
| Health or Medical | Clinical evidence or expert opinion | Lack of peer-reviewed studies; anecdotal evidence only |
| Performance or Efficacy | Testing under typical use conditions | Laboratory testing not reflective of real-world use |
| Comparative Claims | Head-to-head testing against named competitor | Testing against outdated or unrepresentative competitor products |
| Environmental or Green | Third-party certification or validated methodology | Vague terms like natural or eco-friendly without specifics |
| Price or Savings | Documented baseline and calculation method | Inflated reference prices; misleading savings percentages |
5. Strategic Evaluation of Marketing Exposure
Corporations should periodically audit their marketing materials and substantiation files to identify potential vulnerabilities before regulators or private plaintiffs do. This audit should evaluate whether each material claim is supported by adequate substantiation, whether disclaimers are clear and conspicuous, and whether the overall net impression of marketing materials could mislead consumers. When vulnerabilities are identified, the company can modify claims, strengthen substantiation, or enhance disclaimers proactively.
Consulting with counsel experienced in advertising, marketing, and promotions law before launching new campaigns or entering new product categories can prevent costly litigation and regulatory enforcement. The cost of preventive legal review is typically far lower than the cost of defending against FTC enforcement, state attorney general investigations, or class action litigation. A corporation that can demonstrate to a court that it exercised reasonable care in substantiating its claims, maintained compliant disclaimers, and acted in good faith to comply with applicable law presents a substantially stronger defense than one that appears to have rushed claims to market without adequate review.
Forward-looking strategy requires that corporations document their substantiation decisions and compliance processes contemporaneously. Maintain written records of how claims were developed, what substantiation was considered, and why final language was selected. Before any significant marketing campaign, ensure that internal stakeholders sign off on substantiation adequacy and compliance. These steps create a clear record of reasonable corporate diligence and significantly strengthen any marketing defense if regulatory or litigation challenges arise later.
24 Apr, 2026
